PMDA — authorised 21 September 2018
- Marketing authorisation holder: Pfizer Japan Inc
- Status: approved
🇯🇵 Lorbrena in Japan
PMDA authorised Lorbrena on 21 September 2018
Marketing authorisation
Lorbrena in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Lorbrena approved in Japan?
Yes. PMDA authorised it on 21 September 2018.
Who is the marketing authorisation holder for Lorbrena in Japan?
Pfizer Japan Inc holds the Japanese marketing authorisation.